In aesthetic medicine, hyaluronidase is often perceived as something scarier than the filler itself. Patients fear that after its use, "the whole face will disappear," lips will collapse, skin will deteriorate, or the results they paid for over the years will be lost. However, in real clinical practice, hyaluronidase is not a punishment for a failed procedure or a "terrifying beauty solvent." It is an enzyme that can break down hyaluronic acid-based fillers, assist with tissue overload, product migration, unwanted nodules, persistent swelling, and in emergency situations, be part of urgent care for vascular complications.

The intense fear surrounding hyaluronidase arises because patients only see the final action: the product "removes" the filler. But the doctor must see something else - the reason why the filler needs to be removed. If the product is too superficial, has migrated beyond the desired area, accumulated after several procedures, or is compressing tissues, refusing to dissolve it may be a worse decision than using hyaluronidase itself.

Therefore, the main question is not: "Is hyaluronidase dangerous?" It's more appropriate to ask: in what situation is it being offered, which specific filler needs to be dissolved, are there signs of complications, is it a planned correction, does the doctor know the material they are working with, and do they have a plan in case of an adverse reaction. These answers distinguish a medical approach from panic or the frivolous "if anything, we'll dissolve it."

Why Hyaluronidase Causes Fear in Patients

The fear of hyaluronidase has not only a medical but also a psychological reason. Fillers are often associated with the expectation of a better appearance, increased confidence, a "fresh" face, or the return of features that have changed with age. If a patient has spent a long time shaping their lips, cheeks, chin, or the contour of the lower third, the suggestion to dissolve the filler may sound like an admission that all previous work was a mistake.

Additionally, social media amplifies this fear. Calm cases where a doctor partially dissolved excess filler, tissues stabilized, and the patient achieved a more natural result are rarely seen. Instead, dramatic stories spread quickly: "after hyaluronidase, the face collapsed," "lips disappeared," "skin worsened," "I'll never dissolve anything again." Some of these stories may be real, but without clinical context, they frighten more than they explain.

One of the main mistakes is perceiving any dissolution as the destruction of results. In reality, hyaluronidase is used in very different situations. There is emergency administration in suspected vascular occlusion. There is planned partial dissolution of filler migration in the lips. There is work with a superficial product under the eyes that gives a bluish tint. There is correction of excess volume when the face has become heavy or swollen. These are different tasks, and they should not be mixed into one frightening phrase "they will dissolve my face."

A common myth is that hyaluronidase "dissolves everything." In reality, the doctor works with a specific area, dose, and task. Another myth is that after hyaluronidase, tissues necessarily become worse. Often, the patient simply sees the area without the artificially added volume they have become accustomed to. If lips have been maintained with filler for several years, after dissolution, they may appear smaller, softer, or less defined. This does not always mean damage - sometimes it is a return to the actual state of the tissues.

There is also the opposite extreme: treating hyaluronidase as an easy "undo" button. This approach is also dangerous. If a doctor or patient thinks "let's try more filler, and if we don't like it - we'll dissolve it," it reduces responsibility before the first procedure. Hyaluronidase allows for the correction of some problems, but it should not justify aggressive volumes, weak planning, or work in questionable areas without clear indications.

In the work "Guidelines for the Safe Use of Hyaluronidase in Aesthetic Medicine, Including a Modified High-Dose Protocol", published in The Journal of Clinical and Aesthetic Dermatology, hyaluronidase is described not as a cosmetic "anti-filler," but as a product with specific indications, risks, and requirements for safe use. This approach is important: it simultaneously removes unnecessary demonization and does not allow the enzyme to be treated lightly.

When Hyaluronidase is Needed Immediately

The most serious situation where hyaluronidase may be needed is a vascular complication after the injection of a hyaluronic acid-based filler. It occurs when the filler enters a vessel or compresses it from the outside. As a result, the blood supply to the tissues is disrupted, and the area begins to receive less oxygen. If blood flow is not restored, ischemia, necrosis, scarring, deformation, and in certain anatomical scenarios, vision impairment may develop.

For the patient, it is important to know not the treatment schemes, but the alarming signs. Severe or unusual pain, sudden pallor, a marbled or reticulated skin pattern, a cold area, increasing pain, a color change to bluish or dark, sensory disturbances, vision deterioration, eye pain, or sudden visual symptoms after fillers - this is not a situation for waiting in a "let's see tomorrow" style.

Ordinary swelling after injection is indeed possible. Bruising is also possible. But a dangerous mistake is to explain all symptoms as a "normal reaction" without assessing the clinical picture. In a vascular problem, time matters. Hyaluronidase in such a situation is needed not to make the result more beautiful, but to attempt to quickly break down the hyaluronic filler and reduce the obstruction to blood flow.

In the work "Hyaluronidase in Dermal Filler Complications: A Review of Evidence and Recommendations", published in Journal of Cosmetic Dermatology, the authors consider vascular occlusion as one of the key situations where hyaluronidase is of fundamental importance. The important emphasis of such reviews is not just the fact of enzyme administration, but the speed of recognizing the complication, the sufficiency of the dose, repeated tissue evaluation, and readiness to continue treatment if the response is incomplete.

This is where fear of hyaluronidase can become dangerous. In a planned aesthetic situation, the patient has time to think, get a second opinion, discuss partial or phased dissolution. In suspected ischemia, the logic is different. Delaying due to fear "what if too much dissolves" can cost the tissues much more than the product itself.

On Cosmet.Info, the topic of consensus recommendations on vision loss after fillers has already been discussed. Hyaluronidase does not replace an emergency route, ophthalmological care, or an interdisciplinary approach, but it remains an important tool when the problem is related specifically to a hyaluronic acid-based filler.

For the clinic, this means a simple but strict requirement: if a specialist works with hyaluronic fillers, they must understand how to act in case of vascular complications. Having the product in the office is only part of the safety. Protocols, symptom recognition skills, readiness for repeated administration, documentation, observation, and, if necessary, quick involvement of other specialists are needed.

When Filler Dissolution is Done Planned

Planned dissolution is a completely different scenario. There is no acute threat to the tissues, but there is an undesirable result or a change in tissues that should not be corrected with a new portion of filler. In planned cases, calm diagnostics are especially important: what was injected, where the product lies, how much there might be, is there inflammation, is there migration, is the problem really related to the filler.

One of the most common examples is filler migration in the lips. The patient may see a ridge above the upper lip, a blurred contour, or feel that the lips have become "not their own." There is often a temptation to simply add a little more product to "fix the shape." But if the problem is migration, adding new volume may only worsen the deformation. In such a case, partial or complete dissolution of the old material may not be a step back, but the beginning of normal correction.

The area under the eyes is another complex example. There are thin tissues, a tendency to swelling, and high visual visibility of even small changes. A patient may come with dark circles or a "tired look," receive a filler, and after some time face chronic swelling, a bluish tint, or heaviness under the eyes. If the cause is a superficial or excessive hyaluronic filler, the attempt to add more product often worsens the situation.

In the midface, an undesirable result may be less obvious. For example, a filler in the zygomatic or nasolabial area sometimes gives not a "lift," but a feeling of heaviness. The face looks denser, swollen, less mobile. The patient may think they lack more volume, although the problem is actually tissue overload. Here, dissolution can help restore proportion, not just remove "excess beauty."

In the lower third of the face and chin area, excess filler can create unnatural stiffness, massiveness, or change facial expressions. What looked like a clear contour in photos immediately after the procedure may begin to be perceived as heaviness over time. In such cases, it is important not to automatically "correct," but to understand whether the previous correction itself has become part of the problem.

A separate scenario is the Tyndall effect. It occurs when a hyaluronic filler lies too superficially and gives a bluish or grayish tint, especially in thin tissues. The patient may try for months to cover this with cosmetics or care, although the reason is mechanical: the product is not where it should be. If it is indeed a hyaluronic filler, hyaluronidase can be a logical solution.

Nodules and indurations require an even more cautious approach. Not every induration after a filler needs to be dissolved immediately. The cause may be product accumulation, an inflammatory reaction, a biofilm problem, fibrous changes, or another process. The tactic depends on the time of appearance, pain, redness, tissue temperature, procedure history, and type of injected material. In such cases, hyaluronidase may be part of the treatment, but it should not replace diagnosis.

To better distinguish typical situations, it is convenient to look not only at the external manifestation but also at the clinical logic of the decision:

Situation What the patient may see Why hyaluronidase may be needed
Vascular complication Severe pain, pallor, marbled pattern, cold area, color change Try to quickly break down the HA filler and reduce the obstruction to blood flow
Filler migration Ridge above the lip, blurred contour, unnatural shape Remove or reduce the product that has migrated beyond the desired area
Tyndall effect Bluish or grayish tint in thin tissues Dissolve superficially located hyaluronic filler
Tissue overload Heavy, swollen, or "overdone" face Reduce excess volume and restore a more natural proportion
Nodules or indurations Dense area, unevenness, sometimes discomfort Help if the problem is related specifically to HA filler, but diagnosis is needed first

This is where ultrasound diagnostics become useful. If the doctor sees where the filler lies, whether there is product accumulation, how superficial it is, whether there are signs of altered tissues, dissolution can be more precise and less "blind." This does not mean that ultrasound is always needed, but in cases of migration, indurations, repeat corrections, and complex history, it can significantly change the plan. This topic has already been covered in the Cosmet.Info material on ultrasound before fillers and injection cosmetology safety.

Planned dissolution has another important feature: it can be partial and phased. It is not always necessary to "remove everything." Sometimes it is enough to reduce the excess, remove the superficial layer, solve the migration problem, or prepare the tissues for a new, more thoughtful correction. This should be discussed before the procedure so that the patient does not expect either an immediate ideal or a catastrophic reset.

What Happens After Hyaluronidase Injection

Hyaluronidase is an enzyme that breaks down hyaluronic acid. To put it simply, it helps "disassemble" the hyaluronic gel from which the HA filler is made. In scientific descriptions, its action is associated with breaking the bonds in the hyaluronic acid molecule, reducing the viscosity of the extracellular matrix, and increasing tissue permeability. For aesthetic practice, the main thing is that the filler loses its structure and gradually stops functioning as a volumetric gel.

But different fillers dissolve differently. They may differ in the degree of cross-linking, density, hyaluronic acid concentration, depth of injection, procedure age, and how tissues have reacted to the product. A fresh superficial filler and an old dense material in a deeper layer are different clinical tasks. That is why sometimes the result is visible quickly, and sometimes repeated procedures or a phased approach are needed.

It is also important to understand that hyaluronidase is not a universal remedy for all fillers. It primarily works with hyaluronic acid-based products. If there is a biostimulator, calcium hydroxyapatite-based product, poly-L-lactic acid, silicone, or permanent material in the tissues, the logic will be different. That is why the phrase "they injected something, dissolve it" is not sufficient medical information.

In the work "The Use of Hyaluronidase in Aesthetic Medicine: Formulations, Physicochemical Properties, and Clinical Application", published in Journal of Clinical Medicine, the authors focus on the diversity of products, dosing strategies, injection techniques, and clinical scenarios. This is important for practice: hyaluronidase is not a "one-size-fits-all" dose, but a tool that requires understanding of the specific task.

After hyaluronidase injection, the patient may see changes quite quickly, but evaluating the final appearance immediately is not always correct. There may be swelling, redness, sensitivity, bruising, or temporary unevenness. If a significant volume was dissolved, the area may look sharply less filled. This does not always mean a bad result - sometimes tissues just need time to calm down.

One of the most common fears is "it will dissolve my own hyaluronic acid." Theoretically, the enzyme can affect not only the injected filler, as hyaluronic acid is part of the natural extracellular matrix. But the body's own hyaluronic acid is constantly renewing. In most aesthetic situations, the main visible effect is associated with the loss of added volume, not the destruction of the face as such.

This does not mean that hyaluronidase is absolutely safe and does not require caution. Allergic reactions are possible, including rare serious reactions. Local adverse effects are possible. An excessive aesthetic effect is possible if more is dissolved than the patient expected. Therefore, planned administration should include explaining risks, assessing medical history, understanding expectations, and readiness for observation after the procedure.

The issue of allergy testing should not be presented simplistically. In planned situations, the doctor can consider the allergic history, previous reactions, product characteristics, and local protocols. But in suspected vascular occlusion, testing or long waiting should not delay urgent care. In such cases, the risk of ischemia may be much more serious.

When can filler be reintroduced after hyaluronidase? There is no universal answer. After planned dissolution, it is often worth giving tissues time to stabilize so as not to build a new result on swelling or inflammation. After complications, the decision depends on the condition of the tissues, the cause of the problem, the area, the technique, and the patient's readiness. It is important not to rush to repeat the same correction that already led to the need for dissolution.

What Mistakes Patients and Doctors Make

The first mistake is to inject over the problem. If there is filler migration, superficial product, persistent swelling, or tissue overload, additional filler may temporarily mask the defect, but often worsens the overall picture. The patient gets more volume but does not get better structure. After some time, the problem returns in a more complex form.

The second mistake is to dissolve without diagnosis. If the doctor does not know what product was injected, when, in what quantity, and at what depth, the decision becomes less accurate. This is especially true for patients with a long history of procedures with different specialists. In such cases, it is sometimes better to first gather maximum information, conduct an examination, use ultrasound if necessary, and only then decide if hyaluronidase is needed.

The third mistake is to promise the patient an ideal result in one go. Sometimes one injection is enough. But with old, dense, deep, or excessive filler, several stages may be needed. If the patient is not warned about this, a normal medical process will be perceived as a failure.

The fourth mistake is to fear hyaluronidase where it is urgently needed. If there are signs of vascular complications, the main risk is not that "the result will be ruined," but that tissues may suffer due to disrupted blood flow. In such situations, aesthetic concerns take a back seat.

The fifth mistake is to use hyaluronidase as an excuse for an aggressive injection strategy. If a doctor regularly creates excessive volumes and then offers to "just dissolve," this is not a sign of a modern approach. Competent aesthetic medicine should strive for less trauma, better planning, and less need for corrections.

The sixth mistake is not talking to the patient about the psychological side. For the doctor, dissolution may be a technical procedure, but for the patient, it is an emotional loss of an image they are accustomed to. If this is not discussed, even the correct medical decision may leave the person dissatisfied.

What to Ask the Doctor Before Dissolution

The patient does not need to know all protocols and dosages. But they have the right to understand the logic of the procedure. A good first question: "What exactly are we dissolving?" If the answer is unclear, it is worth clarifying whether the doctor believes the problem is related specifically to a hyaluronic filler or if there are doubts about the type of product.

The second question: "Is this an emergency situation or a planned correction?" This determines the pace of decisions. If there is suspicion of a vascular complication, action is needed quickly. If it is about lip migration or excess volume, there is time to discuss the plan, the amount of dissolution, possible stages, and the expected appearance after the procedure.

The third question: "Can partial dissolution be done?" It is not always necessary to remove the entire filler. In some cases, it is enough to reduce the excess or correct a specific area. But this depends on the area, type of filler, its location, and the doctor's capabilities.

The fourth question: "Is ultrasound needed?" It is not mandatory in every case, but it can be useful for old fillers, indurations, migration, unknown products, or suspected vascular problems. If the doctor explains why ultrasound is needed or why it can be omitted in a specific case, it is better than an automatic response "not needed" or "mandatory for everyone."

The fifth question: "What are the risks and what will happen after the procedure?" The patient should know about possible swelling, bruising, temporary asymmetry, feeling of volume loss, risk of allergic reaction, and the need for a follow-up visit. This should not be frightening, but it should be discussed.

The sixth question: "When can a new correction be planned?" If the doctor immediately promises to quickly dissolve everything and just as quickly reintroduce the filler without assessing the tissues, caution is warranted. In many cases, it is the pause after dissolution that helps to see the real anatomy and not repeat the old mistake.

Conclusions

Hyaluronidase is not a product to be automatically feared. But it is also not a simple cosmetic "undo button." Its strength lies in its ability to break down hyaluronic acid-based fillers and give the doctor control in situations where the filler is incorrectly placed, creates an undesirable aesthetic effect, or threatens tissues.

In emergency cases, hyaluronidase can be part of urgent care for vascular complications. In planned situations, it helps remove migration, excess volume, superficial filler, asymmetry, or the consequences of previous procedures. But in both cases, one thing is important: the product must be used by a specialist who understands anatomy, complications, filler types, dosages, risks, and the limits of the method.

For the patient, the best position is not to panic or romanticize. If the doctor suggests hyaluronidase, it is worth asking why it is needed in your specific case, which filler is planned to be dissolved, what will happen without this procedure, whether ultrasound is needed, what result is expected, and whether it is an emergency situation or a planned correction.

Thus, hyaluronidase does not "destroy beauty." In the right hands, it helps correct mistakes, reduce risks, treat complications, and restore a more natural appearance to the face. The most dangerous thing is not the product itself, but the situation where it is feared so much that necessary treatment is postponed, or used so lightly that thinking stops before the first injection.